FIELD: microbiology. SUBSTANCE: invention aims at revealing and isolating peptides fixed by means of bacterial adhesion to elastic epithelial tissues of mammary gland that can be used in vaccines for prevention of mastitis of agricultural animals. In order to reveal specific proteins in bacteria, e.g. in strain aureus, capable of sticking or not sticking to elastic epithelial cells, walls of bacterial cells are isolated and extracted. Proteins present in adhering cells and missing in other cells are used for preparing peptide subfragment. This peptide constitutes base of mastitis vaccine. EFFECT: provided effective mastitis vaccine blocking adhesion of strain aureus to elastic epithelial cells. 8 cl, 1 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING OF RECOMBINANT PLASMID DNA AND A METHOD OF PREPARING OF ZYMOGENIC FORM OF HUMAN PROTEIN C | 0 |
|
SU1838411A3 |
METHOD OF PREPARING OF ZYMOGENIC FORM OF HUMAN C-PROTEIN | 1989 |
|
RU2018535C1 |
GLP-I-MOLECULAR COMPLEX, PHARMACEUTICAL COMPOSITION AND METHOD OF COMPLEX PREPARING | 1995 |
|
RU2147588C1 |
METHOD FOR CONSTRUCTION OF RECOMBINANT PLASMID DNA, ENCODING HUMAN ZYMOGEN C | 0 |
|
SU1739854A3 |
METHOD OF PREPARING OF HUMAN RECOMBINANT ACTIVATED PROTEIN C | 0 |
|
SU1830081A3 |
RABIES VACCINE | 2014 |
|
RU2712743C2 |
VACCINATION USING THE ALPHA 3 DOMAIN OF MICA/B FOR CANCER TREATMENT | 2016 |
|
RU2747296C2 |
BIOLOGICAL MATERIALS FOR MODULATING IMMUNE RESPONSES | 2017 |
|
RU2770060C2 |
FUSION CONSTRUCTION CONTAINING CELL PENETRATING PEPTIDE, POLYEPITOPE AND TLR PEPTIDE AGONIST, INTENDED FOR TREATMENT OF CANCER | 2017 |
|
RU2807135C2 |
VACCINE CONSTRUCTS AND THEIR APPLICATIONS AGAINST STAPHYLOCOCCUS INFECTIONS | 2017 |
|
RU2766354C2 |
Authors
Dates
2000-01-10—Published
1994-11-04—Filed